File(s) not publicly available
The pharmaceutical industry and access and benefit-sharing
presentation
posted on 2023-06-08, 06:48 authored by Florian KernMy contribution is based on an analysis of the voluntary realisation of the Access and Benfit-Sharing (ABS) stipulations of the UN Convention on Biological Diversity (CBD) by the pharmaceutical industry. Our research shows that on a voluntary basis the pharmaceutical industry realises ABS provisions of the CBD only to a very limited extent. We thus argue for the necessity of an legally binding ABS protocol on the basis of the Bonn guidelines.
History
Publication status
- Published
Publisher
Federal Agency for Nature Conservation, GermanyPages
3.0Presentation Type
- paper
Event name
European Regional Meeting on an Internationally Recognized Certificate of Origin / Source / Legal ProvenanceEvent location
Isle of Vilm, Germany.Event type
conferenceEvent date
24 - 29 October 2006.Department affiliated with
- SPRU - Science Policy Research Unit Publications
Full text available
- No
Peer reviewed?
- Yes
Editors
F Wolff, U FeitLegacy Posted Date
2012-02-06Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC